119 related articles for article (PubMed ID: 2582782)
1. Influence of erythropoietin treatment on endocrine abnormalities in haemodialyzed patients.
Kokot F; Wiecek A; Grzeszczak W; Klepacka J; Klin M; Lao M
Contrib Nephrol; 1989; 76():257-70; discussion 270-2. PubMed ID: 2582782
[No Abstract] [Full Text] [Related]
2. Influence of long-term erythropoietin therapy on endocrine abnormalities in haemodialyzed patients.
Kokot F; Wiecek A; Schmidt-Gayk H; Marcinkowski W; Nieszporek T; Rudka R; Trembecki J
Przegl Lek; 1992; 49(1-2):43-9. PubMed ID: 1455006
[TBL] [Abstract][Full Text] [Related]
3. [The effect of erythropoietin treatment on endocrine organ function in patients with terminal-stage kidney failure on hemodialysis].
Kokot F; Wiecek A; Grzeszczak W; Klin M; Klepacka J; Lao M
Ter Arkh; 1991; 63(6):86-9. PubMed ID: 1948756
[TBL] [Abstract][Full Text] [Related]
4. Influence of long-term erythropoietin treatment on plasma levels of calcium-phosphate related hormones in haemodialyzed uraemic patients.
Kokot F; Wiecek A; Marcinkowski W; Schmidt-Gayk H; Rudka R; Trembecki J
Ann Univ Mariae Curie Sklodowska Med; 1994; 48 Suppl 3():9-16. PubMed ID: 8192535
[TBL] [Abstract][Full Text] [Related]
5. Effects of the evening i.v. administration of erythropoietin in haemodialyzed patients.
Buemi M; Allegra A; Laganà A; Aloisi C; Privitera M; Morabito N; Frisina N
Riv Eur Sci Med Farmacol; 1993; 15(5-6):195-7. PubMed ID: 7761669
[TBL] [Abstract][Full Text] [Related]
6. Hypothalamo-pituitary-adrenal axis in uraemia: evidence for primary adrenal dysfunction?
Grant AC; Rodger RS; Mitchell R; Gibson S; White A; Robertson WR
Nephrol Dial Transplant; 1993; 8(4):307-10. PubMed ID: 8390003
[TBL] [Abstract][Full Text] [Related]
7. Changes in partition of extracellular fluid volumes in anemic dialyzed uremic patients after partial correction of the anemia with recombinant human erythropoietin treatment.
Cannella G; Guerra UP; Sandrini M; Gaggiotti M; Traverso GB; Rolla D; Marsano L; Mulas D
Clin Nephrol; 1993 Sep; 40(3):164-7. PubMed ID: 8403572
[TBL] [Abstract][Full Text] [Related]
8. [The endocrine system and aging].
Gerlach J
Pol Tyg Lek; 1982 Sep; 37(34-35):1025-7. PubMed ID: 6761662
[No Abstract] [Full Text] [Related]
9. Changes in endocrinological functions in hemodialysis patients associated with improvements in anemia after recombinant human erythropoietin therapy.
Akizawa T; Kinugasa E; Nakayama F; Takahashi T; Koshikawa S; Shimizu N
Contrib Nephrol; 1990; 82():86-93. PubMed ID: 2093532
[No Abstract] [Full Text] [Related]
10. Erythropoietin for the anemia of chronic renal failure.
Schwartz AB; Prior J; Terzian L; Kahn B
Am Fam Physician; 1988 Jun; 37(6):211-5. PubMed ID: 3289343
[No Abstract] [Full Text] [Related]
11. Peripheral hemodynamics, blood viscosity, and the renin-angiotensin system in hemodialysis patients under therapy with recombinant human erythropoietin.
Steffen HM; Brunner R; Müller R; Degenhardt S; Pollok M; Lang R; Baldamus CA
Contrib Nephrol; 1989; 76():292-8. PubMed ID: 2582783
[TBL] [Abstract][Full Text] [Related]
12. Function of endocrine organs in hemodialyzed patients of long-term erythropoietin therapy.
Kokot F; Wiecek A; Schmidt-Gayk H; Marcinkowski W; Gilge U; Heidland A; Rudka R; Trembecki J
Artif Organs; 1995 May; 19(5):428-35. PubMed ID: 7625922
[TBL] [Abstract][Full Text] [Related]
13. [Quinbolone in the therapy of anemia in uremic patients during periodic hemodialytic treatment].
Amato M; Bigioli F; Beconi D; Martinelli F; Lapini V; Salvadori M
Clin Ter; 1980 Jul; 94(1):57-65. PubMed ID: 7438723
[No Abstract] [Full Text] [Related]
14. Does anemia correction by rHuEPO improve uremic cardiopathy?
Carletti P; Bibiano L; Boggi R; Taruscia D; Mioli V
Kidney Int Suppl; 1993 Jun; 41():S70-1. PubMed ID: 8320949
[TBL] [Abstract][Full Text] [Related]
15. [Gynecomastia in the uremic patient undergoing periodic hemodialytic treatment].
Sodi A; Rizzo M; Somigli M
Minerva Nefrol; 1969; 16(6):420-4. PubMed ID: 5403806
[No Abstract] [Full Text] [Related]
16. Effects of long-term erythropoietin therapy on fibrinolytic system in haemodialyzed patients.
Pawlak K; Pawlak D; Mysliwiec M
Thromb Res; 2008; 121(6):787-91. PubMed ID: 17869326
[TBL] [Abstract][Full Text] [Related]
17. Long-term erythropoietin therapy does not affect endothelial markers, coagulation activation and oxidative stress in haemodialyzed patients.
Pawlak K; Pawlak D; Mysliwiec M
Thromb Res; 2007; 120(6):797-803. PubMed ID: 17391740
[TBL] [Abstract][Full Text] [Related]
18. Influence of general anesthesia and surgical stress on endocrine function.
Oyama T
Contemp Anesth Pract; 1980; 3():173-84. PubMed ID: 6260426
[No Abstract] [Full Text] [Related]
19. Effect of erythropoietin administration in uremia.
Gurland HJ; Samtleben W; Schmidt B
Contrib Nephrol; 1989; 70():172-7. PubMed ID: 2670428
[No Abstract] [Full Text] [Related]
20. Anemia and erythropoietin in hemodialysis and continuous ambulatory peritoneal dialysis.
Korbet SM
Kidney Int Suppl; 1993 Feb; 40():S111-9. PubMed ID: 8445832
[No Abstract] [Full Text] [Related]
[Next] [New Search]
